Trial intelligence / Profile preview

Low-dose dexmedetomidine vs propofol for prevention of postoperative delirium after hip fracture surgery in elderly patients

TCTR20190522001Phase 4Completed

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, propofol in postoperative delirium (POD), sponsored by Ratchadaphiseksomphot Endowment Fund. Started May 2019; status: completed.

02

Drugs

dexmedetomidinepropofol
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on TCTR20190522001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190522001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call